News Sentiment

U2TH34 sentiment intelligence

United Therapeutics Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 53 Balanced news tone 14 relevant articles
Exchange SAO Brazil
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 137.50 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 14

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+0.0% over one week, +0.0% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend active 0.0% over four weeks
Fair value 44.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 8
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 14
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
GuruFocus 5
Investing.com South Africa 2
Market source 2
EBC Financial Group 1
Proactive financial news 1
timothysykes.com 1
Clinical Trials Arena 1
StockInvest.us 1

Event Lens

What the news is about

Classified themes
Market update 10
Earnings 2
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-14 of 14